|
Global High Content Screening (HCS) Market Drivers and Restraints Forecast 2015 to 20
Global High Content Screening (HCS) Market Drivers and Restraints Forecast 2015 to 2025; Future Market Insights
High content screening (also k**wn as visual screening and high content analysis) is a method that is used in the process of drug discovery and biological analysis for the identification of the small molecules and peptides. High content screening technique is widely accepted by pharmaceutical and biotech**logy companies for the validation, identification of potential toxicities and to elucidate drug’s mechanism of action (MOA). HCS technique commonly uses living cell for biological research purpose to elucidate working of diseased and **rmal cells. The growth of high content screening market is mainly attributed to increasing need of toxicity studies in early stage of drug discovery processes. For example, high content screening is considered as most important technique in pharmaceutical research and development for measuring biological pathways and drug target effects. In addition, consistent efforts of key players in order to develop **vel and advanced tech**logy-based high content screening systems will further stimulate the growth of the market. For example, Perkin Elmer, Inc. offers Opera Phenix High Content Screening System featured with confocal solution for high content application. This system provides high throughput and phe**typic screening for complex disease models like live cells and microtissues. Thus, these types of launches will attract more number of customers to use high content screening services that will drive the growth of high content screening market. Furthermore, increasing investments and funding by the **rth American and European governments for the research activities of pharmaceutical and biotech**logical companies ultimately increases the uptake of high content screening techniques and hence drives the growth of the market. However, these techniques demands higher capital investments that will restrain the growth of high content screening market. In addition, lack of skilled and k**wledgeable personnel coupled with high cost of high content screening techniques will further restrain the overall growth of high content screening market. The market of High Content Screening (HCS) can be categorized into:
Geographically, **rth America represents the largest market of high content screening. The growth is mainly attributed to advancement in tech**logies and presence of large number of domiciled key players (e.g. Perkin Elmer, Inc., Molecular Devices, Thermo Fisher Scientific and others) in **rth America. In addition, collaboration of many key players aiming to develop **vel high content screening tech**logies coupled with increasing acceptance of these tech**logies also drives the growth of the market. Europe is considered as the second largest market of high content screening owing to increasing healthcare investments of European government. In addition, Asia-Pacific region is the emerging markets for high content screening market because of increasing awareness about these tech**logies coupled with positive initiatives by Asia-Pacific government toward the development of healthcare infrastructure may also boost the growth of high content screening market in this region. Various key players contributing to the global high content screening market comprises Molecular Device, Becton, Dickinson and Company, Thorlabs, Inc., Perkin Elmer, Inc., Thermo Fisher Scientific, GE Healthcare Lifesciences, Merck Millipore and others. The report covers exhaustive analysis on:
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-eco**mic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies. Report Highlights:*
About Us Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services which are personalized in nature. FMI delivers a complete packaged solution, which combines current market intelligence, statistical anecdotes, tech**logy inputs, valuable growth insights and an aerial view of the competitive framework and future market trends. Our research services cover global as well as regional emerging markets such as GCC, ASEAN and*BRICS. Our offerings cover a broad spectrum of industries including Chemicals, Materials, Energy, Tech**logy, Healthcare and Retail. FMI’s operating model blends cross-disciplinary research experience to deploy in-depth, insightful and actionable research. Contact* Ms Christina Johnsan 3rd Floor, 207 Regent Street, London – W1B 3HH United Kingdom T:*+ 44 (0) 20 7692 8790 D:*+44 (0) 20 3287 4268 USA Tel:*+1-347-918-3531 Email:*[email protected] Website:*www.futuremarketinsights.com The post Global High Content Screening (HCS) Market Drivers and Restraints Forecast 2015 to 2025; Future Market Insights appeared first on Medgadget. http://feeds.feedburner.com/~ff/Medgadget?d=yIl2AUoC8zA http://feeds.feedburner.com/~ff/Medgadget?d=qj6IDK7rITs http://feeds.feedburner.com/~ff/Medg...ck:gIN9vFwOqvQ http://feeds.feedburner.com/~r/Medgadget/~4/SeVaw5HH2R4 |
| الساعة الآن 04:11 PM |
Powered by vBulletin® Copyright ©2000 - 2026, Jelsoft Enterprises Ltd. TranZ By
Almuhajir